Sildenafil Impact on Ventricular Function in Patients With Heart Failure
Heart Failure
About this trial
This is an interventional treatment trial for Heart Failure focused on measuring Heart failure
Eligibility Criteria
Inclusion Criteria: Patients with heart failure in stable clinical condition compatible with New York Heart Association functional class I to III. Eligibility criteria is consent to participate in the study after receiving detailed information about procedures, possible clinical benefits, and risks.
Exclusion Criteria: patients with new diagnosed lesions during the procedure, eg pulmonary mass and important claustrophobia, low blood pressure ( systolic blood pressure <90 mmHg or diastolic blood pressure <60 mmHg) nitrate or nebivolol use over the last 48 hours, metallic non MRI compatible implantable devices.
Sites / Locations
- Hospital Ana Neri - MRI unit
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Sildenafil
Placebo
12 patients will be in this group. They will take a sildenafil 50mg.
12 patients will be in this group, they will take placebo